CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized Cannabinoids, Opioids and Other Pharmaceutical Agents
February 21, 2018 09:02 ET
|
CTT Pharmaceutical Holdings, Inc.
HAMILTON, Ontario, Feb. 21, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in novel drug delivery...
CTT Pharmaceutical Holdings, Inc., (CTTH) Announces U.S. Patent for Therapeutic Composition for Treating Psoriasis with Cannabidiol and Corticosteroids
January 10, 2018 06:30 ET
|
CTT Pharmaceutical Holdings, Inc.
HAMILTON, Ontario, Jan. 10, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in novel drug delivery...